Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients.

ABSTRACT:

SUBMITTER: Santini V 

PROVIDER: S-EPMC7932918 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature